Tag: Infographics

IFPMA 2015 pharma by numbers
6 ways to getting the supply chain in sync
Translating principles into practice - The pharmaceutical industry's efforts to work towards universal health coverage (UHC)
Good pharmacovigilance principles to ensure biotherapeutics safety
1. Counterfeit medicines in legitimate supply chains, A study by University of California, San Diego School of Medicine & the Pharmaceutical Security Institute (PSI)
2. Counterfeit medicines in legitimate supply chains, a study by University of California, San Diego School of Medicine & the Pharmaceutical Security Institute (PSI)
3. Counterfeit medicines in legitimate supply chains, a study by University of California, San Diego School of Medicine & the Pharmaceutical Security Institute (PSI)
4. Counterfeit medicines in legitimate supply chains, a study by University of California, San Diego School of Medicine & the Pharmaceutical Security Institute (PSI)
Counterfeit medicines in legitimate supply chains SDCP & PSI Study
Partners in the fight against malaria: Efforts of the R&D Pharmaceutical Industry
Partners in the fight against malaria: malaria today
Partners in the fight against malaria: simple interventions that save lives
Partners in the fight against malaria: challenges
Partners in the fight against malaria: doing our part
Partners in the global fight against tuberculosis
Tuberculosis today
Challenges
Doing our part: Efforts of the research-based pharmaceutical industry to fight TB
Pharmaceutical industry and global health
Improving prevention of women’s cancers in Latin America and The Caribbean
1) Did you know? Improving prevention of women’s cancers in Latin America and The Caribbean
2) Did you know? Improving prevention of women’s cancers in Latin America and The Caribbean
3) Did you know? Improving prevention of women’s cancers in Latin America and The Caribbean
Doing our part: Partnerships to boost R&D for unmet medical needs
Doing our part: landmark medicine donations
Doing our part: Comprehensive efforts to fight NTDs
Doing our part: Implementation of capacity-building efforts
A check-list for transferring technologies
Maintaining the vaccines innovation edge
The Exciting journey of a vaccine

Other Tags

Access Access to antiretrovirals Access to Medicines Access to vaccines Africa AMR AMR Industry Alliance Anti-Counterfeit Antibiotics antimicrobial resistance antivirals Biosimilars Biotherapeutic Medicines Biotherapeutics Cancer Clinical Trials Code of Practice collaboration Counterfeit Medicines Counterfeits COVID-19 COVID-19 vaccines Dementia Developing World Diabetes Economic footprint Epidemics Ethics Event Highlights Fake Medicines Fakes Falsified Medicines Fight the Fakes Flu Global Health global health security harmonization Health Health Partnerships HIV/AIDS IFPMA IFPMA Assembly IFPMA Statement Immunization Incremental Innovation Influenza Infographic Infographics Innovation Innovation ecosystem Intellectual Property IP Malaria MDGs Medicines Mental and Neurological Disorders NCDs Neglected Tropical Diseases News Releases Non-Communicable Diseases Novel Coronavirus (COVID-19) NTDs pandemic Pandemic Influenza Pandemic preparedness pandemics partnership Partnerships Pharma Pharmacovigilance Position Paper Prevention Publications Public Health Quality R&D Regulatory regulatory systems Related Links Research Safety SDGs Seasonal Influenza Statements Supply chain Sustainable Development Goals Sustainable Innovation trade Treatments Tuberculosis UHC Universal Health Coverage Vaccine Vaccines Value of Innovation Videos WHA WHO WIPO Women’s Cancers